Avisa Diagnostics Stock Net Income
Fundamental analysis of Avisa Diagnostics allows traders to better anticipate movements in Avisa Diagnostics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Avisa |
Avisa Diagnostics Company Net Income Analysis
Avisa Diagnostics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Avisa Diagnostics Net Income | (715.76 K) |
Most of Avisa Diagnostics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avisa Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Avisa Diagnostics reported net income of (715,762). This is much lower than that of the sector and significantly lower than that of the Net Income industry. The net income for all United States stocks is notably higher than that of the company.
Avisa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avisa Diagnostics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Avisa Diagnostics could also be used in its relative valuation, which is a method of valuing Avisa Diagnostics by comparing valuation metrics of similar companies.Avisa Diagnostics is currently under evaluation in net income category among its peers.
Avisa Fundamentals
| Return On Equity | -2.89 | |||
| Return On Asset | -1.41 | |||
| Current Valuation | 9.09 M | |||
| Shares Outstanding | 75.62 M | |||
| Price To Book | 12.76 X | |||
| Price To Sales | 12.69 X | |||
| Revenue | 277.83 K | |||
| Gross Profit | 129.28 K | |||
| EBITDA | (678.64 K) | |||
| Net Income | (715.76 K) | |||
| Cash And Equivalents | 97.6 K | |||
| Total Debt | 153.44 K | |||
| Current Ratio | 0.39 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (452.28 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.0266 | |||
| Market Capitalization | 988 | |||
| Total Asset | 122.16 K | |||
| Z Score | -14.5 | |||
| Net Asset | 122.16 K |
About Avisa Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avisa Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avisa Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avisa Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Avisa Pink Sheet
Avisa Diagnostics financial ratios help investors to determine whether Avisa Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avisa with respect to the benefits of owning Avisa Diagnostics security.